Director of Pricing
Garner HealthFull Time
Junior (1 to 2 years)
The Executive Director, Commercial Data Strategy and Analytics should have a strong track record in building and scaling global commercial data ecosystems. Experience in the biopharmaceutical industry, specifically with NASH therapeutics like Rezdiffra, is essential. The role requires oversight of commercial analytics and data management teams, with a need for cross-functional insight generation across U.S. and ex-U.S. markets. Expertise in integrating specialty pharmacy, hub, claims, CRM, payer, and EMR data is crucial, along with a deep understanding of commercial data governance, quality standards, and lifecycle management. Proficiency in advanced analytics, AI, and data science capabilities, including predictive analytics and next-best-action engines, is necessary. Experience managing relationships with analytics vendors and data aggregators such as IQVIA, Symphony, Veeva, and Snowflake is also required.
The Executive Director will define and lead a multi-year commercial data and analytics vision and strategy, developing a roadmap to evolve commercial data capabilities, tools, and infrastructure. They will identify and prioritize high-value commercial analytics capabilities to support Rezdiffra's growth and champion advanced AI and data science capabilities. This role involves owning the global commercial data strategy, ensuring scalable integration of various data sources, and partnering with IT on commercial data governance, quality standards, and best practices. The Executive Director will support the development and adoption of enterprise predictive-analytics products, translate their outputs into commercial action plans, and own BI development of key dashboards. They will oversee the delivery of integrated insights and analytics across global and U.S. markets, establish a unified global KPI framework, and manage the commercial analytics team, including brand analytics leadership. Additionally, the role involves managing end-to-end visibility into the patient experience through data integration, supporting brand teams with actionable insights, building and mentoring a high-performing analytics team, and leading relationships with key analytics vendors and data aggregators.
Develops therapies for neurological disorders
Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.